Hongyan Wang, PA-C

Hongyan Wang practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Hongyan Wang's NPI, 1518041888, was assigned on October 24, 2006. Hongyan Wang holds Texas license PA03664.

Hongyan Wang's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Hongyan Wang's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Hongyan Wang practices. Vendor and product names are available with a free account.

Physician assistant is Hongyan Wang's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Hongyan Wang is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Hongyan Wang is licensed in Texas.

CMS data shows 101 Medicare services from Hongyan Wang across 2 procedure codes in 2024, for 97 Medicare patients. Medicare paid $5,948 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 97 Medicare patients who saw Hongyan Wang in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Hongyan Wang's median patient age at 72, with 52% women.

In 2024, Hongyan Wang wrote 186 Medicare Part D claims for 52 patients. 89% of them were for generic drugs. CMS names the drug for 116 of them, across 5 drugs with 11 or more claims each, at $8,056 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Hongyan Wang for performance year 2024, reported as part of a group. Hongyan Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Hongyan Wang, published from 2012 to 2019.

CMS Open Payments shows 12 general payments to Hongyan Wang from 9 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Genmab U.S., Inc. paid the most, $130.

Hongyan Wang is a member of AAPA.